2 years ago

Microplate Dx Raises £2.5M Seed Funding to Combat Antimicrobial Resistance

  • Scottish health tech startup Microplate Dx has raised £2.5 million in a seed funding round to further develop its rapid diagnostic platform for bacterial infections

  • The platform aims to combat antimicrobial resistance by quickly identifying the most effective antibiotics for treatment.

      • ProblemHealthcare

      "Antimicrobial resistance is a growing global threat, causing over 1.2 million deaths annually. Current methods for identifying effective antibiotics can take up to two days, leading to delays in treatment and potentially life-threatening consequences."

      Solution

      "Microplate Dx has developed a rapid diagnostic platform that uses a proprietary data processing algorithm to test the antibiotic susceptibility of bacterial infections within an hour. This allows doctors to quickly identify the most effective treatment for patients, reducing the risk of antibiotic resistance and improving patient outcomes."

      Covered on